OMER OZKAN DUMAN

Dr. OMER OZKAN DUMAN

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ODOMER OZKAN DUMAN
OMER OZKAN DUMAN
ÜTÜmmü Taş
Ümmü Taş
STSedat Taş
Sedat Taş
EAErkan Alpaslan
Erkan Alpaslan
Background: Obesity is an independent and major risk factor for cardiovascular diseases. However, the presence of common comorbidities such as diabetes and hypertension makes it difficult to understand the direct impact of obesity on the myocardium. The aim of this study is to evaluate the isolated effects of weight loss achieved after bariatric surgery on left ventricular (LV) geometry and diastolic functions in individuals with the “Metabolically Healthy Obese” (MHO) phenotype. Materials and Methods: The study included 28 patients (Surgical Group) who underwent Laparoscopic Sleeve Gastrectomy (LSG) between January 2022 and December 2025, had a preoperative Body Mass Index (BMI) > 40 kg/m2, and had no known cardiovascular or metabolic diseases. The control group consisted of 25 age- and gender-matched metabolically healthy morbidly obese patients who had not undergone surgery. Demographic and echocardiographic data of all participants were analyzed at baseline and at 6 months. Results: Weight Loss: In the surgical group, BMI decreased from 46.21 kg/m2 to 37.11 kg/m2 at the 6th month, while no significant change was observed in the control group. Cardiac Structure: In the surgical group, Left Ventricular Mass Index was significantly decreased from 51.11 g/m2 to 44.57 g/m2. Cardiac Function: The E/A ratio, an indicator of diastolic function, increased significantly from 1.19 to 1.34 in the surgical group, indicating notable improvement. No clinically meaningful change in systolic function was detected. Metabolic Parameters: The surgical group exhibited marked improvements in glucose and lipid profiles (decrease in Total Cholesterol, increase in HDL). Conclusions: The study demonstrates that bariatric surgery, independent of metabolic comorbidities, directly provides “reverse remodeling” of cardiac structure and improves function through reduction of adipose tissue and alleviation of hemodynamic load. These results support the effectiveness of surgery in reducing cardiovascular risk and preserving cardiac structure even in morbidly obese patients without comorbidities.

5 January 2026 in Pakistan Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
ODOMER OZKAN DUMAN
OMER OZKAN DUMAN
EAErkan Alpaslan
Erkan Alpaslan
Objective: To compare the changes in levels of inflammation markers in the patient with non-valvular atrial fibrillation (NVAF) who were on Warfarin and then switched to Apixaban. Methodology: The files of 149 consecutive patients, who had NVAF, who were previously using Warfarin, but for various reasons switched to Apixaban were screened retrospectively. Forty-one patients were excluded from the study. Last coagulation parameters were used for analysis. The evaluation of hemogram parameters in patients undergoing treatment with Warfarin, subsequently transitioning to Apixaban, revealed significant insights into various hematological indices. Notably, the Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, the Systemic Immune-Inflammation Index, Systemic Inflammation Response Index (SIRI), the aggregate index of systemic inflammation and Monocyte/Lymphocyte Ratio were meticulously assessed and compared between the groups. Results: The study involved 108 individuals with NVAF. The average lymphocyte level of the patients on Apixaban therapy was statistically significantly higher than on Warfarin therapy (p<0.001). Also, The Neutrophils (p<0.001), Monocytes (p=0.008), and Platelets (p<0.001) were significantly lower in patients treated with Apixaban compared to those on Warfarin. When the systemic inflammation indices of the patients were compared, the averages of the patients’ NLR, PLR, MLR, SII, SIRI, and AISI indices were statistically and significantly lower than time on Warfarin therapy. Conclusion: Current study results suggested that Apixaban has more effective anti-inflammatory potential compared to Warfarin. The study implicates new perspectives on the anti-inflammatory effects of oral anticoagulants used in the treatment of NVAF.

1 January 2015
Verified
Book Chapter
Closed access
PDF file
ODOMER OZKAN DUMAN
OMER OZKAN DUMAN

5 August 2026
Verified
Book
Open access
PDF file
ÇÜÇağla Akçay Ürkmez
Çağla Akçay Ürkmez
MAMehmet Zafer AYDIN
Mehmet Zafer AYDIN
MTMehmet Kamil TEBER
Mehmet Kamil TEBER
MPMüzeyyen Gizem Parmak
Müzeyyen Gizem Parmak
MAMuhammet Salih Ateş
Muhammet Salih Ateş
AYAhmet Kenan Yalta
Ahmet Kenan Yalta

5 August 2026
Verified
Book Chapter
Closed access
ODOMER OZKAN DUMAN
OMER OZKAN DUMAN
Bu bölüm, Desmoplakin (DSP) geni mutasyonu zemininde gelişen Aritmojenik Kardiyomiyopati (AK) ve eşlik eden kutanöz bulguları (kardiyokutanöz sendrom) detaylı bir klinik olgu üzerinden incelemektedir. Klasik sağ ventrikül tutulumunun ötesinde, DSP mutasyonlarında sol veya biventriküler etkilenimin çok daha erken ve baskın görülebileceği vurgulanmaktadır. Bölümde, halı sahada ani kardiyak ölüm ile kaybedilen genç bir hastanın aile taraması sonucunda; palmar keratoderma, elektrokardiyografik sol prekordiyal (V5-V6) T dalga negatifliği, sağ ventrikül diskinezisi ve miyokardiyal fibrozis (LGE) saptanan iki kardeşin tıbbi değerlendirmesi sunulmaktadır. 2024 Avrupa Görev Gücü (ETF) kriterleri ışığında teşhis edilen bu özgün fenotipin patofizyolojisi, genetik mimarisi ve klinik gidişatı belirleyen inflamatuar "hot phase" (miyokardit benzeri) atakları güncel literatür eşliğinde tartışılmaktadır. Ayrıca, ani kardiyak ölümün önlenmesinde spor kısıtlamasının, farmakoterapinin, primer koruma amaçlı İmplante Edilebilir Kardiyoverter Defibrilatör (ICD) kullanımının ve kaskad aile taramasının hayati önemi çizilmektedir. This chapter examines Arrhythmogenic Cardiomyopathy (AC) and its associated cutaneous manifestations (cardiocutaneous syndrome) driven by Desmoplakin (DSP) gene mutations, presented through a detailed clinical case. Beyond classic right ventricular involvement, the text highlights that DSP mutations frequently present with early and dominant left or biventricular disease. It details the familial cascade screening of a young patient who suffered sudden cardiac death during sports, revealing palmar keratoderma, left precordial (V5-V6) T-wave inversions, right ventricular dyskinesia, and myocardial fibrosis (LGE) in his siblings. Evaluated according to the 2024 European Task Force (ETF) diagnostic criteria, the pathophysiology, genetic architecture, and "hot phase" (myocarditis-like) inflammatory episodes of this unique phenotype are discussed alongside current literature. Furthermore, the chapter underscores the critical importance of exercise restriction, pharmacotherapy, Implantable Cardioverter Defibrillators (ICD) for primary prevention, and genetic screening in preventing sudden cardiac death.

Verified
Journal Article
Open access
PDF file
ODOMER OZKAN DUMAN
OMER OZKAN DUMAN
LDLale Duman
Lale Duman
Background: Pulmonary Alveolar Proteinosis (PAP) is a rare interstitial lung disease characterized by intra-alveolar accumulation of lipoproteinaceous material. Although its radiologic features are well documented, the disease’s impact on cardiovascular mechanics—specifically right ventricular (RV) adaptation—remains underexplored. This study aims to explore the correlation between radiologic severity of parenchymal involvement, quantified by high-resolution computed tomography (HRCT) scores, and right heart hemodynamics, with a focus on RV-pulmonary artery (RV-PA) coupling and interventricular interaction. Methods: This retrospective observational study analyzed 13 adult patients with confirmed PAP and 70 age- and sex-matched healthy controls. All participants underwent concurrent thoracic HRCT and transthoracic echocardiography. Structural lung damage and “crazy-paving” patterns were quantified using a total lobar HRCT score ranging from 0 to 30. Echocardiographic evaluation assessed right heart hemodynamics, using the tricuspid annular plane systolic excursion-to-systolic pulmonary artery pressure ratio (TAPSE/sPAP) as an index of RV-PA coupling and the RV/LV ratio. Given the small sample size, p-values for correlations were adjusted for multiple comparisons using the Bonferroni method, and findings should be regarded as exploratory. Results: Left ventricular parameters were preserved across both groups. However, PAP patients had significantly impaired right heart indices compared with controls, including a larger RV basal diameter (37.2 ± 2.3 vs. 32.6 ± 1.6 mm, p < 0.001), higher sPAP (38.5 ± 3.5 vs. 23.6 ± 2.9 mmHg, p < 0.001), and a higher RV/LV ratio (0.98 ± 0.19 vs. 0.60 ± 0.06, p < 0.001). Furthermore, the RV-PA coupling marker, TAPSE/sPAP, was markedly reduced in the PAP cohort (0.43 ± 0.07 vs. 0.88 ± 0.13 mm/mmHg, p < 0.001). After Bonferroni correction, elevated HRCT scores remained strongly associated with a higher RV/LV ratio (r = 0.89, p < 0.001) and a lower TAPSE/sPAP ratio (r = −0.90, p < 0.001). Subgroup analysis indicated that patients with severe radiological scores had more pronounced RV enlargement and lower RV-PA coupling reserves. Conclusions: In this exploratory analysis, radiographic severity of alveolar lipoproteinaceous accumulation in PAP was strongly associated with isolated right ventricular dysfunction and impaired RV-PA coupling, despite preserved left heart function. These hypothesis-generating findings suggest that echocardiographic assessment of TAPSE/sPAP and RV/LV ratios may be useful for the clinical follow-up of PAP patients; however, causality cannot be inferred from this small, retrospective, single-center cohort, and larger prospective studies are warranted.